Literature DB >> 20453396

Baroreflex sensitivity predicts cardiovascular events in patients with type 2 diabetes mellitus without structural heart disease.

Norihiro Okada1, Naohiko Takahashi, Kunio Yufu, Yukichi Murozono, Osamu Wakisaka, Tetsuji Shinohara, Futoshi Anan, Mikiko Nakagawa, Masahide Hara, Tetsunori Saikawa, Hironobu Yoshimatsu.   

Abstract

BACKGROUND: Cardiovascular autonomic neuropathy is a major complication in patients with diabetes mellitus (DM). However, the relationship between cardiovascular autonomic neuropathy and the incidence of cardiovascular events has been poorly investigated in type 2 DM. The present study aimed to assess the long-term cardiovascular predictive value of baroreflex sensitivity (BRS) in Japanese patients with type 2 DM without structural heart disease. METHODS AND
RESULTS: BRS was evaluated using the phenylephrine method in 210 patients with type 2 DM who did not have structural heart disease or other severe complications. BRS was considered depressed if <6 ms/mmHg. Accurate follow-up information for 3-10 years (mean 4.7 years) was obtained in 184 patients (90 females, 94 males; mean age 58+/-12 years). The initial onset of a major adverse cardiovascular event (MACE) was investigated. During follow-up, 19 patients presented with a MACE (4 cardiovascular deaths, 3 nonfatal myocardial infarctions, 4 coronary revascularizations, 5 strokes, 2 congestive heart failures). Cox proportional hazards regression analysis revealed that depressed BRS was independently associated with the incidence of MACE (hazard ratio 1.93, 95% confidence interval 1.09-3.82, P=0.0236).
CONCLUSIONS: Depressed BRS at baseline has long-term cardiovascular predictive value in Japanese patients with type 2 DM without structural heart disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20453396     DOI: 10.1253/circj.cj-09-0960

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  18 in total

1.  Insulin: a sweet deal for human baroreflex function.

Authors:  Virginia L Brooks
Journal:  J Physiol       Date:  2010-10-01       Impact factor: 5.182

Review 2.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

3.  Rosiglitazone improves insulin sensitivity and baroreflex gain in rats with diet-induced obesity.

Authors:  Ding Zhao; Belinda H McCully; Virginia L Brooks
Journal:  J Pharmacol Exp Ther       Date:  2012-07-18       Impact factor: 4.030

4.  Impaired baroreflex gain during pregnancy in conscious rats: role of brain insulin.

Authors:  Afaf S Azar; Virginia L Brooks
Journal:  Hypertension       Date:  2010-12-13       Impact factor: 10.190

5.  Arterial pressure lability is improved by sodium-glucose cotransporter 2 inhibitor in streptozotocin-induced diabetic rats.

Authors:  Tomoko Yoshikawa; Takuya Kishi; Keisuke Shinohara; Ko Takesue; Risa Shibata; Noriyuki Sonoda; Toyoshi Inoguchi; Kenji Sunagawa; Hiroyuki Tsutsui; Yoshitaka Hirooka
Journal:  Hypertens Res       Date:  2017-02-16       Impact factor: 3.872

6.  Baroreflex deficiency induces additional impairment of vagal tone, diastolic function and calcium handling proteins after myocardial infarction.

Authors:  Cristiano Mostarda; Bruno Rodrigues; Alessandra Medeiros; Edson D Moreira; Ivana C Moraes-Silva; Patricia C Brum; Katia De Angelis; Maria-Cláudia Irigoyen
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

7.  Leptin acts in the forebrain to differentially influence baroreflex control of lumbar, renal, and splanchnic sympathetic nerve activity and heart rate.

Authors:  Baoxin Li; Zhigang Shi; Priscila A Cassaglia; Virginia L Brooks
Journal:  Hypertension       Date:  2013-02-19       Impact factor: 10.190

8.  Interference with peroxisome proliferator-activated receptor-γ in vascular smooth muscle causes baroreflex impairment and autonomic dysfunction.

Authors:  Giulianna R Borges; Donald A Morgan; Pimonrat Ketsawatsomkron; Aaron D Mickle; Anthony P Thompson; Martin D Cassell; Durga P Mohapatra; Kamal Rahmouni; Curt D Sigmund
Journal:  Hypertension       Date:  2014-06-09       Impact factor: 10.190

Review 9.  Neural tone and cardio-renal outcomes in patients with type 2 diabetes mellitus: a review of the literature with a focus on SGLT2 inhibitors.

Authors:  Mouhamed Nashawi; Omar Sheikh; Ayman Battisha; Abdullah Ghali; Robert Chilton
Journal:  Heart Fail Rev       Date:  2020-11-09       Impact factor: 4.214

10.  Sites and sources of sympathoexcitation in obese male rats: role of brain insulin.

Authors:  Zhigang Shi; Ding Zhao; Priscila A Cassaglia; Virginia L Brooks
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-01-22       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.